Show simple item record

dc.contributor.authorKaaijk, Patricia
dc.contributor.authorWijmenga-Monsuur, Alienke J
dc.contributor.authorvan Houten, Marlies A
dc.contributor.authorVeldhuijzen, Irene K
dc.contributor.authorTen Hulscher, Hinke I
dc.contributor.authorKerkhof, Jeroen
dc.contributor.authorvan der Klis, Fiona R
dc.contributor.authorvan Binnendijk, Rob S
dc.date.accessioned2019-07-29T09:37:19Z
dc.date.available2019-07-29T09:37:19Z
dc.date.issued2019-04-23
dc.identifier.issn1537-6613
dc.identifier.pmid31112277
dc.identifier.doi10.1093/infdis/jiz188
dc.identifier.urihttp://hdl.handle.net/10029/623164
dc.language.isoenen_US
dc.subjectMumpsen_US
dc.subjectantibody responseen_US
dc.subjectimmunogenicityen_US
dc.subjectmeasles-mumps-rubella (MMR) vaccineen_US
dc.subjectsafetyen_US
dc.titleA Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults.en_US
dc.typeArticleen_US
dc.identifier.journalJ Infect Dis 2019; advance online publication (ahead of print)en_US
dc.source.journaltitleThe Journal of infectious diseases


This item appears in the following Collection(s)

Show simple item record